16 May 2014

Interview with Ms. Mithra Bindhu by Ed Miseta, Chief Editor, Outsourced Pharma and Clinical Leader

Article information

Mithra Bindhu is the founder and one of the principal investors of Asiatic Clinical Research, a CRO that is headquartered in India. Ed Miseta, Chief Editor, Outsourced Pharma and Clinical Leader spoke with her and the following are the highlights.

Asiatic caters to biotech and small- to medium-sized pharma companies in the U.S. and Europe. Asiatic's primary strength has been in helping companies to rescue clinical trials gone wrong. DCG(I), the regulator in India has recently made an attempt to overhaul the entire system for performing trials in India; the effort has taken too long and has made the system too complicated. However, the positive outcome of the regulatory overhaul is that patient compensation is clear, ethics committees are registered, doctors can conduct only three trials concurrently, and more.

The long term these changes will be good for both the industry and patients. The process to bring medicines to market can be quicker if trials can be more adaptive. Mithra believes several things can help to speed the process - arriving at a success/fail decision faster, reduction in time by using web based technology to capture data and reducing costs by integrating remote monitoring.

May 2010

Mumbai Angels invests in Asiatic Clinical Research
Copyright © 2011 Asiatic Clinical Research Pvt. Ltd All rights reserved.
Privacy Policy